Robert Andrade - 28 Mar 2025 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FENC	Restricted Share Unit	Award	$0	+75,000	+10%	$0.000000	827,722	28 Mar 2025	Common Shares	75,000	$0.000000	Direct	F1, F2
transaction	FENC	Stock Options	Award	$0	+50,000	+6%	$0.000000	877,722	28 Mar 2025	Options	50,000	$6.50	Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	On March 28, 2025, Robert Andrade was awarded restricted share units to acquire 75,000 shares of the issuer's common shares pursuant to the issuer's 2020 Equity Incentive Plan
F2	One-third of the shares subject to this award shall be released from restriction as of March 28, 2026 (the "Vesting Commencement Date"). One twenty-fourth of the shares subject to this award may be released from restriction as of the last day of each month following the Vesting Commencement Date. As of February 29, 2028 and thereafter, 100% of the total number of shares subject to this award shall be released from restriction.
F3	On March 28, 2025, Robert Andrade was granted incentive stock options to purchase 50,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan.
F4	One-third of the shares subject to this option may be exercised as of March 28, 2026 ("Vesting Commencement Date"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of February 29, 2028, 100% of the total number of shares subject to this option shall be vested.